InvestmentMay 26, 2026, 08:02 AM
Rani Therapeutics Raises $20M in Registered Direct Offering
AI Summary
Rani Therapeutics announced a registered direct offering to raise approximately $20.0 million in gross proceeds. The offering includes the sale of 12,476,637 shares of Class A common stock at $1.07 per share and 6,214,953 pre-funded warrants at $1.0699 per warrant. A sovereign wealth fund is leading the investment, alongside other new and existing healthcare-focused funds, with the closing expected around May 27, 2026.
Key Highlights
- Rani Therapeutics expects to raise approximately $20.0 million in gross proceeds.
- The offering includes 12,476,637 shares of Class A common stock at $1.07 per share.
- It also includes 6,214,953 pre-funded warrants at $1.0699 per warrant.
- The exercise price for each pre-funded warrant is $0.0001 per share.
- A sovereign wealth fund is leading the investment, alongside other funds.
- The offering is expected to close on or about May 27, 2026.
Price Impact
More from RANI